As of 06 Nov 2026 05:25 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2021/014 (18 Mar 2021): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Irbesartan/hydrochlorothiazide 150mg/12.5mg tabletsaffected product · inferred from phrasing | Out of stock, as stated | early May 2021precision: early in the month · window end 10 May 2021, derived from “early May 2021” | notice of 18 Mar 2021 |
| Irbesartan/hydrochlorothiazide 300mg/12.5mg tabletsaffected product · inferred from phrasing | Out of stock, as stated | early June 2021precision: early in the month · window end 10 Jun 2021, derived from “early June 2021” | notice of 18 Mar 2021 |
| Of the separate components, only irbesartan 150mg tabletsnamed by the source as remaining available · inferred from phrasing | Stated as available⚠ the source line states more than one status — first stated shown | — not stated for this line | notice of 18 Mar 2021 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Of the separate components, only irbesartan 150mg tablets — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Irbesartan
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 18 Mar 2021. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 18 Mar 2021 | Medicine Supply Notification: Irbesartan/ hydrochlorothiazide 150mg/12.5mg tablets - Update | Supply notification | Tier 2 | MSN/2021/014 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2021)13 Irbesartan/hydrochlorothiazide 150mg/12.5mg tablets · issued 23 Mar 2021 · valid until early May 2021, as stated · matched by name PDF ↗